Oral fluid testing: promises and pitfalls
| dc.contributor.author | Huestis, Marylin A. | |
| dc.contributor.author | Verstraete, Alain | |
| dc.contributor.author | Kwong, Tai C. | |
| dc.contributor.author | Morland, Jorg | |
| dc.contributor.author | Vincent, Michael J. | |
| dc.contributor.author | Torre Fornell, Rafael de la | |
| dc.date.accessioned | 2019-02-18T12:00:56Z | |
| dc.date.available | 2019-02-18T12:00:56Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | Oral fluid is a promising new matrix for drug-testing programs for drug treatment, the workplace, pain management, and driving under the influence of drugs (DUID)7. As with any new technology, there are strengths and limitations. We discuss with international experts the role this new alternative matrix will play in diverse drug-monitoring settings, and the research, development, and legislation needed to permit oral fluid testing to best take its place in the modern laboratory armamentarium. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clin Chem. 2011 Jun;57(6):805-10. DOI: 10.1373/clinchem.2010.152124 | |
| dc.identifier.doi | http://dx.doi.org/10.1373/clinchem.2010.152124 | |
| dc.identifier.issn | 0009-9147 | |
| dc.identifier.uri | http://hdl.handle.net/10230/36614 | |
| dc.language.iso | eng | |
| dc.publisher | American Association for Clinical Chemistry | |
| dc.relation.ispartof | Clinical Chemistry. 2011 Jun;57(6):805-10 | |
| dc.rights | © 2016 American Association for Clinical Chemistry | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.subject.other | Saliva | |
| dc.subject.other | Abús de substàncies | |
| dc.subject.other | Drogues -- Control | |
| dc.title | Oral fluid testing: promises and pitfalls | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/acceptedVersion |
Files
Original bundle
1 - 1 of 1
